United States News Todas as matérias

PayPal Holdings (NASDAQ:PYPL) today announced fourth-quarter and full-year 2025 results, marking a pivotal turning point in its multi-year turnaround.

Atlanta-based RPC (NYSE:RES), a leading provider of oilfield services, reported financial results for the fourth quarter and full year ended December 31, 2025.

Pfizer (NYSE:PFE) reported fourth-quarter and full-year 2025 results on Tuesday, February 3, 2026, signaling a definitive shift away from its pandemic-era reliance.

Merck (NYSE:MRK) today reported fourth-quarter and full-year 2025 results that showcased a tale of two portfolios: a surging oncology and respiratory business set against a dramatic collapse in vaccine demand from China.

Marathon Petroleum (NYSE:MPC) reported fourth-quarter and full-year 2025 results on Tuesday, February 3, 2026, punctuated by a massive rebound in refining profitability and a peer-leading capital return program.

MPLX LP (NYSE:MPLX) reported fourth-quarter and full-year 2025 results on Tuesday, delivering record adjusted EBITDA of $7 billion and reinforcing its position as a primary cash engine for parent company Marathon Petroleum (NYSE:MPC).

CorVel (NASDAQ:CRVL) reported strong financial results for the quarter and nine months ended December 31, 2025, driven by the aggressive integration of generative and "agentic" artificial intelligence across its risk management platforms.

Ingredion (NYSE:INGR) reported record full-year 2025 results on Tuesday, underscoring the resilience of its high-margin specialty ingredients despite operational headwinds in North America.

Atkore (NYSE:ATKR) reported first-quarter fiscal 2026 results on Tuesday, February 3, 2026, revealing a sharp decline in profitability as the company navigates a challenging "pricing normalization" cycle in its core electrical conduit business.

Archer Daniels Midland (NYSE:ADM) reported fourth-quarter and full-year 2025 results on Tuesday that reflected a challenging cyclical downturn for the global grain giant.

Ball Corporation (NYSE:BALL) reported fourth-quarter and full-year 2025 results on Tuesday that showcased record cash flow and a massive shareholder return program, even as the company navigated the final phase of its post-aerospace-divestiture restructuring.

Massimo Group (NASDAQ:MAMO) announced on Tuesday that it has entered into a non-binding letter of intent to acquire 100% of FST Development Company, a move that signals the powersports manufacturer’s aggressive pivot toward AI-driven hardware and digital health robotics.

Vertex Pharmaceuticals (NASDAQ:VRTX) and WuXi Biologics announced a major license and research service agreement on Monday, February 2, 2026, aimed at developing an innovative trispecific T-cell Engager (TCE) for B-cell mediated autoimmune diseases.

Leiden, Netherlands-based Pharming Group (NASDAQ:PHARM) provided 2026 financial guidance and detailed its rare disease pipeline at its Investor Day on February 3, 2026.

Boeing (NYSE:BA) and Air Cambodia announced the airline's first-ever purchase of Boeing aircraft on Tuesday, unveiling a deal for up to 20 737-8 jets at the 2026 Singapore Airshow.

The U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental Biologics License Application (sBLA) for DATROWAY® (datopotamab deruxtecan), a TROP2-directed antibody-drug conjugate (ADC).

Ares Management (NYSE:ARES) announced Tuesday that it has completed its acquisition of London-based BlueCove, a leader in scientific fixed-income management.

AudioCodes (NASDAQ:AUDC) reported fourth-quarter and full-year 2025 results on Tuesday that highlighted a steady transition toward high-margin software and artificial intelligence services.

Chunghwa Telecom (NYSE:CHT) reported fourth-quarter and full-year 2025 results on Tuesday that marked its highest annual earnings in eight years, fueled by a surge in digital transformation and 5G migration.

The 2026 Grammys have wrapped, triggering an estimated $1.3 billion jump in music streaming as winners and controversy collide.

Elon Musk has fused SpaceX and xAI into a private behemoth worth over $1.25 trillion, with markets already cheering the move.

Twist Bioscience (NASDAQ:TWST) reported first-quarter fiscal 2026 results Monday that beat revenue expectations and showed significant margin improvement, as the company stays on track to reach its profitability goals by the end of the year.

Palantir Technologies (NASDAQ:PLTR) shares jumped in after-hours trading Monday after the data analytics powerhouse reported fourth-quarter and full-year 2025 results that "crushed" consensus expectations.

Snowflake (NYSE:SNOW) and OpenAI announced a $200 million partnership on Monday to integrate advanced artificial intelligence models directly into the Snowflake cloud data platform.